Science and Health News

American Heart Association Rapid Access Journal Report

A type of treatment for multiple sclerosis that 'resets' the immune system may stop progression of the disease in nearly half of patients.

A study led by Queen Mary University of London (QMUL) finds that vitamin D supplements protect against acute respiratory infections including colds and flu.

There’s a multi-billion-dollar industry devoted to products that fight signs of aging, but moisturizers only go skin deep. Aging occurs deeper — at a cellular level — and scientists have found that eating less can slow this cellular process.

What if you could lose weight and reduce your risk of life-threatening disease without any changes in what you eat — other than a five-day special diet once every few months?

A form of RNA released from fat cells into the blood may help to regulate other tissues.

KENILWORTH, N.J.-(BUSINESS WIRE)- Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that it will be stopping protocol 017, also known as the EPOCH study, a Phase 2/3 study evaluating verubecestat, an investigational small molecule inhibitor of the beta-site amyloid precursor protein cleaving enzyme 1 (BACE1), in people with mild-to-moderate Alzheimer’s disease (AD).

The Patent Trial and Appeal Board (PTAB) of the U. S. Patent and Trademark Office (USPTO) today ruled that the inventions claimed in the pending U.S. patent application filed by the Doudna/Charpentier research group and the patents and applications filed by the Broad Institute are separately patentable from one another, thereby moving the Doudna/Charpentier group’s application closer to issuance as a U.S. patent.